Arlene Spencer v. Kelsey-Seybold Medical Group, PLLC, et al.

District Court, S.D. Texas·Decided August 25, 2026·No. 4:22-cv-04354·Unknown

Opinion

UNITED STATES DISTRICT COURT August 25, 2026 SOUTHERN DISTRICT OF TEXAS Nathan Ochsner, Clerk HOUSTON DIVISION ARLENE SPENCER, § § Plaintiff. § § V. § CIVIL ACTION NO. 4:22-cv-04354 § KELSEY-SEYBOLD MEDICAL § GROUP, PLLC, et al., § § Defendants. §

MEMORANDUM AND RECOMMENDATION Pending before me in this putative fraud class action is Plaintiff Arlene Spencer’s motion for class certification. See Dkt. 76 (sealed); Dkt. 83 (redacted). On August 20, 2026, I held a hearing on the motion. See Dkt. 102. Having considered the parties’ briefing, oral arguments, the record, and the applicable law, I recommend the motion be denied. BACKGROUND On November 14, 2022, Spencer filed a putative class action in Harris County District Court against Defendants Kelsey-Seybold Medical Group, PLLC d/b/a Kelsey-Seybold Clinic (“Kelsey-Seybold” or “KSC”) and Laboratory Corporation of America Holdings (“LabCorp”). Since 2008, KSC has been purchasing laboratory services from LabCorp, pursuant to a Laboratory Services Agreement (“LSA”). Spencer argues that she “is the victim of a ‘pass-through’ billing scheme” under which KSC “refers patients to on-site laboratories [known as patient service centers or ‘PSCs’] run by LabCorp for laboratory tests and then bills patients’ insurance companies and/or the patients as if Kelsey-Seybold performed the tests.” Dkt. 101 at 2. According to Spencer, KSC “in turn reimburses LabCorp for the service at a substantially lower price than what it receives from insurance companies/patients, but higher than what LabCorp would have received from payers had LabCorp billed the patients (or their insurers) directly.” Id. Spencer contends that “[t]his manner of circular billing results in substantially higher costs to patients than if LabCorp had billed directly, allowing Kelsey- Seybold and LabCorp to unfairly profit at the expense of patients.” Id. Spencer asserted claims for fraud by nondisclosure and violations of the Texas Deceptive Trade Practices Act (“DTPA”) against both defendants. Spencer also asserted a claim for unconscionability against KSC. On December 15, 2022, LabCorp removed the case to federal district court based on jurisdiction under the Class Action Fairness Act. On February 6, 2023, Spencer filed an amended complaint asserting the same allegations and the same claims against Defendants. See Dkt. 21 (sealed); Dkt. 101 (redacted). On March 31, 2023, Defendants filed motions to dismiss. On December 21, 2023, Judge George C. Hanks, Jr. denied those motions “without prejudice to being reasserted as motions for summary judgment and/or arguments opposing class certification.” Dkt. 44. On February 13, 2026, the court dismissed LabCorp from this case, pursuant to a stipulation between Spencer and LabCorp. See Dkts. 73, 74. On March 31, 2026, Spencer filed her motion for class certification. See Dkt. 76 (sealed); Dkt. 83 (redacted). Spencer seeks: (i) certification of a class of all fee-for-service patients who were billed by Kelsey-Seybold Medical Group PLLC d/b/a Kelsey-Seybold Clinic (“KSC” or “Defendant”) for reference clinical laboratory services and/or pathology laboratory services, performed by Laboratory Corporation of America Holdings (“Labcorp”) where Blue Cross and Blue Shield of Texas, Cigna Healthcare of Texas, Inc., or UnitedHealthcare Insurance Company, either provided insurance coverage or third-party administrative services, between November 15, 2018 through May 3, 2021 . . . ; (ii) the appointment of Arlene Spencer as “Class Representative”; and (iii) the appointment of Wolf Popper LLP (“Wolf Popper”) and Hilder & Associates (“Hilder”) as “Class Counsel” and “Liaison Counsel,” respectively. Dkt. 83 at 14. KSC opposes class certification. See Dkt. 85 (sealed); Dkt. 98 (redacted). LEGAL STANDARD Rule 23 governs whether a proposed class should be certified. “[T]he Rule 23 class-action device was designed to allow an exception to the usual rule that litigation is conducted by and on behalf of the individual named parties only.” Califano v. Yamasaki, 442 U.S. 682, 700–01 (1979). “To come within the exception, a party seeking to maintain a class action must affirmatively demonstrate [its] compliance with Rule 23.” Comcast Corp. v. Behrend, 569 U.S. 27, 33 (2013) (quotation omitted). Rule 23(a) requires that any purported class meet four “prerequisites”: (1) numerosity (a class so large that joinder of all members is impracticable); (2) commonality (questions of law or fact common to the class); (3) typicality (named parties’ claims or defenses are typical of the class); and (4) adequacy of representation (representatives will fairly and adequately protect the interests of the class). Madison v. Chalmette Refin. L.L.C., 637 F.3d 551, 554 (5th Cir. 2011) (cleaned up). These prerequisites—numerosity, commonality, typicality, and adequacy—are necessary but not sufficient conditions for class certification. Rule 23(b) specifies three class types and sets out requirements—beyond those articulated in Rule 23(a)—for each. The putative class here seeks certification under Rule 23(b)(3), which permits class certification where “questions of law or fact common to class members predominate over any questions affecting only individual members, and that a class action is superior to other available methods for fairly and efficiently adjudicating the controversy.” Fed. R. Civ. P. 23(b)(3). In considering a motion for class certification, I “must rigorously consider both Rule 23(a)’s prerequisites and the Rule 23(b) class type.” Chavez v. Plan Benefit Servs., Inc., 957 F.3d 542, 546 (5th Cir. 2020). This rigorous analysis requires me “to go beyond the pleadings to determine whether the requirements of Rule 23 have been met: a court must understand the claims, defenses, relevant facts, and applicable substantive law in order to make a meaningful determination of the certification issues.” Cole v. Gen. Motors Corp., 484 F.3d 717, 724 (5th Cir. 2007) (quotation omitted). “Merits questions may be considered to the extent— but only to the extent—that they are relevant to determining whether the Rule 23 prerequisites for class certification are satisfied.” Amgen Inc. v. Conn. Ret. Plans & Tr. Funds, 568 U.S. 455, 466 (2013). My “obligation . . . to conduct a rigorous analysis of Rule 23’s requirements . . . is not dispensed with by the parties’ stipulation to certification or failure to contest one or more of Rule 23’s requirements.” Ward v. Hellerstedt, 753 F. App’x 236, 244 (5th Cir. 2018). “[T]he court [is] bound to conduct its own thorough . . . inquiry.” Stirman v. Exxon Corp., 280 F.3d 554, 563 n.7 (5th Cir. 2002). As part of this “rigorous analysis,” I must ask whether the proposed class’s damages model “measure[s] only those damages attributable to [its] theory [of liability].” Comcast, 569 U.S. at 35. “Calculations need not be exact, but at the class-certification stage (as at trial), any model supporting a plaintiff’s damages case must be consistent with its liability case, particularly with respect to the alleged effect of the violation.” Ludlow v. BP, P.L.C., 800 F.3d 674, 683 (5th Cir. 2015) (cleaned up) (applying Comcast’s rationale to a putative securities class action); see also Slade v. Progressive Sec. Ins. Co.,

Arlene Spencer v. Kelsey-Seybold Medical Group, PLLC, et al., (S.D. Tex. 2026).

Arlene Spencer v. Kelsey-Seybold Medical Group, PLLC, et al. (Arlene Spencer v. Kelsey-Seybold Medical Group, PLLC, et al.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Stirman v. Exxon Corporation
280 F.3d 554 (Fifth Circuit, 2002)
McManus v. Fleetwood Enterprises, Inc.
320 F.3d 545 (Fifth Circuit, 2003)
Califano v. Yamasaki
442 U.S. 682 (Supreme Court, 1979)
Comcast Corp. v. Behrend
133 S. Ct. 1426 (Supreme Court, 2013)
Southwestern Bell Telephone Co. v. Marketing on Hold Inc.
308 S.W.3d 909 (Texas Supreme Court, 2010)
Southwestern Refining Co., Inc. v. Bernal
22 S.W.3d 425 (Texas Supreme Court, 2000)
B & W SUPPLY, INC. v. Beckman
305 S.W.3d 10 (Court of Appeals of Texas, 2009)
Bradford v. Vento
48 S.W.3d 749 (Texas Supreme Court, 2001)
Amstadt v. United States Brass Corp.
919 S.W.2d 644 (Texas Supreme Court, 1996)
In Re: BP, P.L.C. Securities
800 F.3d 674 (Fifth Circuit, 2015)
Steve Simms v. Jerral Jones
836 F.3d 516 (Fifth Circuit, 2016)
Cheryl Slade v. Progressive Security Insurance
856 F.3d 408 (Fifth Circuit, 2017)
Heriberto Chavez v. Plan Benefit Services
957 F.3d 542 (Fifth Circuit, 2020)
Prantil v. Arkema
986 F.3d 570 (Fifth Circuit, 2021)